Your browser doesn't support javascript.
Considerations for the Surgical Management of Early Stage Lung Cancer During the COVID-19 Pandemic.
Merritt, Robert E; Kneuertz, Peter J.
  • Merritt RE; Thoracic Surgery Division, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: Robert.Merritt@osumc.edu.
  • Kneuertz PJ; Thoracic Surgery Division, The Ohio State University Wexner Medical Center, Columbus, OH.
Clin Lung Cancer ; 22(3): 156-160, 2021 May.
Article in English | MEDLINE | ID: covidwho-622762
ABSTRACT
The highly transmissible novel coronavirus (COVID-19) has infected over 8.8 million people globally and has upended the delivery of health care in the United States, creating unprecedented challenges to providing care to patients with early stage non-small cell lung cancer (NSCLC). The initial surge of patients with COVID-19 that have flooded hospitals has put a strain on physical space, workforce, and supplies. In addition, social distancing and the risk of COVID-19 transmission has created significant barriers for thoracic surgeons to diagnose and treat patients. Many hospitals across the country have temporarily suspended elective operations to preserve hospital beds, ventilators, and personal protective equipment. Currently, the pandemic has greatly disrupted the current standard of resection after adequate staging with imaging and/or surgical staging for early stage NSCLC well beyond the initial acute phase; therefore, a new paradigm for effective management will need to be devised until the COVID-19 pandemic is eradicated with systematic vaccination and herd immunity. Thoracic surgeons will need to recalibrate their approach to ensure that patients receive timely and effective treatment for early stage NSCLC. The management of early stage NSCLC during the COVID-19 pandemic should be balanced with available hospital resources, risk of progression of disease, risk of transmission of COVID-19 to patient and surgeon, and the availability of alternative therapies. This article will address the current challenges with treating early stage NSCLC during the COVID-19 pandemic and provide a clinical framework for providing effective surgical therapy while mitigating the risk of transmission of the SARS-CoV-2 virus to patients and surgeons.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / COVID-19 / Lung Neoplasms Type of study: Diagnostic study / Observational study / Prognostic study / Systematic review/Meta Analysis Topics: Traditional medicine / Vaccines Limits: Humans Language: English Journal: Clin Lung Cancer Journal subject: Neoplasms Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / COVID-19 / Lung Neoplasms Type of study: Diagnostic study / Observational study / Prognostic study / Systematic review/Meta Analysis Topics: Traditional medicine / Vaccines Limits: Humans Language: English Journal: Clin Lung Cancer Journal subject: Neoplasms Year: 2021 Document Type: Article